These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 132272)

  • 1. Decreased ability of blood leukocytes from patients with tumors of the urinary bladder to act as stimulator cells in mixed leukocyte culture.
    Herr HW; Bean MA; Whitmore WF
    Cancer Res; 1976 Aug; 36(8):2754-60. PubMed ID: 132272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocompetence of patients with transitional cell carcinoma as measured by dinitrochlorobenzene skin tests and in vitro lymphocyte function.
    Bean MA; Schellhammer PS; Herr HW; Pinsky CM; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):111-4. PubMed ID: 155219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder.
    Herr HW; Bean MA; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):177-81. PubMed ID: 155221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of restricted suppressor T-cell activity in man.
    Bean MA; Kodera Y; Cummings KB; Bloom BR
    J Exp Med; 1977 Nov; 146(5):1455-60. PubMed ID: 144770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression of the generation of cell-mediated cytotoxicity by macrophage-like suppressor cells in bladder carcinoma patients.
    Spina CA; Dorey F; Vescera C; Brosman S; Fahey JL
    Cancer Res; 1981 Nov; 41(11 Pt 1):4324-30. PubMed ID: 6458353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
    Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
    J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro immune parameters in relation to clinical course in transitional cell carcinoma.
    Cummings KB; Kodera Y; Bean MA
    Natl Cancer Inst Monogr; 1978 Dec; (49):119-22. PubMed ID: 155220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect.
    Engleman EG; Benike CJ; Hoppe RT; Kaplan HS; Berberich FR
    J Clin Invest; 1980 Jul; 66(1):149-58. PubMed ID: 6447164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitional cell carcinoma: circulating tumor antigen correlated with presence/absence of tumor (leukocyte migration assay).
    Bowen JG
    Natl Cancer Inst Monogr; 1978 Dec; (49):245-7. PubMed ID: 748778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activity.
    Baxevanis CN; Reclos GJ; Sfagos C; Doufexis E; Papageorgiou C; Papamichail M
    Clin Exp Immunol; 1987 Feb; 67(2):362-71. PubMed ID: 2955971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in lymphocyte activity after thermal injury. The role of suppressor cells.
    Miller CL; Baker CC
    J Clin Invest; 1979 Feb; 63(2):202-10. PubMed ID: 155076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cells involved in cell-mediated and transplantation immunity in the normal outbred rabbit. X. The organ sources of the stimulator and responder cells in the mixed leukocyte culture reaction.
    Milthorp P; Richter M
    Immunology; 1979 Jan; 36(1):13-24. PubMed ID: 154469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
    Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA
    J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood mononuclear cells from patients with inflammatory bowel disease exhibit normal function in the allogeneic and autologous mixed leukocyte reaction and cell-mediated lympholysis.
    MacDermott RP; Bragdon MJ; Thurmond RD
    Gastroenterology; 1984 Mar; 86(3):476-84. PubMed ID: 6229444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes.
    Rothberger H; Zimmerman TS; Vaughan JH
    J Clin Invest; 1978 Sep; 62(3):649-55. PubMed ID: 151101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple myeloma: an immunologic profile. I. Peripheral blood studies.
    MacKenzie MR; Paglieroni T
    J Immunol; 1977 May; 118(5):1864-71. PubMed ID: 140196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte migration inhibition in vitro in bladder carcinoma.
    Lavergne JA; Lamm DL; Radwin HM; Harrington JT
    Cancer Res; 1979 Jun; 39(6 Pt 1):1985-8. PubMed ID: 445398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.